Page 776 - Read Online
P. 776

Page 4 of 11                                        Yoneoka et al. Hepatoma Res 2020;6:67  I  http://dx.doi.org/10.20517/2394-5079.2020.57

                                                 Table 1. Cohort characteristics
                           Characteristic
                           Mean age in years (s.d.)                        66.8 (11.3)
                           Males                                           30 (71.4%)
                           Ethnicity
                              Caucasian                                    8 (19.0%)
                              Pacific Islander                             6 (14.3%)
                              Asian                                        26 (61.9%)
                              Hispanic                                     2 (4.8%)
                           Hepatitis B surface Ag positive                 5 (11.9%)
                           Hepatitis B core Ab positive                    6 (14.3%)
                           Hepatitis C positive                            19 (45.2%)
                           Alcohol abuse                                   14 (33.3%)
                           NASH/NAFLD                                      13 (31.0%)
                           Mean BMI (s.d.)                                 26.7 (4.9)
                           BMI 30 or higher                                8 (19.0%)
                           Smoking history                                 27 (64.3%)
                           Diabetes mellitus                               17 (40.5%)
                           Hyperlipidemia                                  19 (45.2%)
                           Hypertension                                    32 (76.2%)
                           ALBI
                              Grade 1                                      19 (45.2%)
                              Grade 2                                      20 (47.6%)
                              Grade 3                                      3 (7.1%)
                           Child-Pugh class
                              A                                            33 (78.6%)
                              B                                            9 (21.4%)
                           Mean AFP in ng/mL (s.d.)                        2023 (7605)
                           Normal AFP                                      24 (57.1%)
                           Mean total tumor size in cm (s.d.)              7.0 (4.0)
                           Number of tumors (s.d.)                         1.71 (1.07)

                           s.d.: standard deviation; NASH: non-alcoholic steatohepatitis; NAFLD: non-alcoholic fatty liver
                           disease; BMI: body mass index; ALBI: albumin-bilirubin; AFP: alpha-fetoprotein

               Statistical analysis
               Receiver operator characteristic (ROC) curves were used to determine optimal NLR and PLR cutoffs.
               Cutoff points were selected by maximizing Youden’s index. Mean comparisons were analyzed using
               Welch’s t-test. Categorical comparisons were performed using Fisher’s exact test. Independent predictors of
               response to treatment were determined using univariate logistic regression. Variables that were significant
               in the univariate analysis were included in the multivariate logistic regression model. Time to progression
               (TTP) was defined as the date of treatment until the date of PD based on mRECIST. Patients who did not
               reach the endpoint were censored based on their last imaging date. TTP was analyzed via the Kaplan-
               Meier method and compared using the log-rank test. All tests were two-tailed, and P < 0.05 was considered
               statistically significant. Statistical analyses were performed using SPSS version 26 (IBM, USA), Jamovi
               version 1.0.8 and GraphPad Prism8 (GraphPad Software, USA).


               RESULTS
               Cohort characteristics
               In this cohort of 1,442 patients with HCC, a total of 276 TARE procedures were performed. Of those
               patients, 77 received TARE as primary treatment for HCC, and 42 patients met criteria for this study. Seven
               patients received a second TARE procedure within a month of the first: six were for bilateral disease, and
               one patient had extensive disease that was completed in 2 separate sessions to treat the entire lobe. The
               characteristics of this cohort are described in Table 1. The mean age of the cohort was 66.8 years [standard
               deviation (s.d.) 11.3 years]. There were 30 males and 12 females. Asian represented the largest ethnicity
   771   772   773   774   775   776   777   778   779   780   781